Agfa HealthCare to highlight IMPAX Cardiovascular IT solutions at EuroPCR

Agfa HealthCare announces today that it will highlight its comprehensive IMPAX Cardiovascular suite of products at the EuroPCR congress, the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), from May 21-24, in Paris, France.

ASE, GE partner in India for cardiovascular ultrasound training

The American Society of Echocardiography (ASE) and GE Healthcare have teamed to provide a cardiovascular ultrasound training event for healthcare providers caring for underserved populations in rural northwest India.

ASNC Releases Dose-Reduction Guidelines for Nuclear Cardiology

Technological improvements in image acquisition and software processing in nuclear cardiology should allow physicians to shave patient imaging times dramatically or cut radiation doses fourfold, according to a new preferred practice statement from the American Society of Nuclear Cardiology (ASNC).

ASE: Are cardiovascular sonographers at high risk of radiation exposure?

There is growing concern among cardiac sonographers about the amount of radiation exposure they experience on the job and few say their workplace has a formal policy to address radiation safety for sonographers, according to a survey conducted by the American Society of Echocardiography.

ASE develops mobile app

The American Society of Echocardiography (ASE) has developed a mobile device application, iASE, which provides summaries of the societys most popular guidelines.

New ASE guidelines offer clarity for right ventricular assessment

The American Society of Echocardiography (ASE) has published new guidelines to improve the existing norms of the right heart in the July issue of the Journal of the American Society of Echocardiography. The recommended procedures will establish a more uniform method of evaluating the size and function of the right ventricle, said the society.

ASE: Biomarkers may predict chemo-related cardiotoxicity

According to research presented during the 21st annual scientific sessions of the American Society of Echocardiography (ASE) in San Diego this week, cardiac troponin plasma concentrations and longitudinal strain can predict the development of cardiotoxicity in patients treated with anthracyclines and trastuzumab chemotherapies.

LightLab Imaging debuts new OCT system at EuroPCR

Optical coherence tomography (OCT) developer LightLab Imaging has launched its C7XR FD-OCT imaging system with the C7 Dragonfly Imaging Catheter at EuroPCR 2009 in Barcelona, Spain.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.